Market shaping interventions have been deployed for over a decade to enable greater access to health products in low- and middle-income countries, though evidence of their impact is limited. This Duke GHIC-led retrospective impact evaluation systematically reviewed the overall progress of market shaping, summarizing the impact, and identifying enablers and barriers to inform future market shaping strategies.